Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Acorda Therapeutics, Inc. - Common Stock
(NQ:
ACOR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acorda Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Acorda Therapeutics Reports First Quarter 2023 Financial Results
May 11, 2023
From
Acorda Therapeutics
Via
Business Wire
3 Penny Stocks to Avoid as Interest Rates Rise in 2023
↗
May 11, 2023
This article reveals the worst penny stocks to invest in for 2023, amid rising interest rates and a deteriorating macro environment.
Via
InvestorPlace
Acorda Therapeutics to Make June 2023 $6.2 Million Interest Payment on Secured Debt in Cash
May 10, 2023
From
Acorda Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 09, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
May 09, 2023
We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday!
Via
InvestorPlace
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
May 09, 2023
Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons, which...
Via
FinancialNewsMedia
Topics
Intellectual Property
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 08, 2023
Via
Benzinga
Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China
May 08, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda First Quarter 2023 Update: Webcast/Conference Call Scheduled for May 11, 2023
May 04, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics to Present INBRIJA® Data at the American Academy of Neurology Annual Meeting
April 24, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Launches INBRIJA® TV Commercial for Parkinson’s Awareness Month
April 03, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&A
March 27, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023
From
Acorda Therapeutics
Via
Business Wire
ESTEVE Launches INBRIJA® in Spain
March 07, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Fourth Quarter/Year End 2022 Update: Webcast/Conference Call Scheduled for March 9, 2023
March 06, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Receives Nasdaq Extension to Meet Minimum Bid Price Requirement
February 14, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics to Present at Sequire Biotechnology Conference
January 31, 2023
From
Acorda Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
January 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
January 05, 2023
Via
Benzinga
Acorda Therapeutics Announces New Agreement with Catalent for Long-Term Global Supply of INBRIJA®
January 05, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Announces Revised Long-Term Financial Guidance
December 22, 2022
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Receives Nasdaq Listing Determination Letter and Plans to Request a Hearing
December 20, 2022
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Makes December 2022 $6.2 Million Interest Payment on Secured Debt in Cash
December 05, 2022
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Announces Passage of Reverse Stock Split Proposal at its Special Meeting of Stockholders
November 11, 2022
From
Acorda Therapeutics
Via
Business Wire
How Is The Market Feeling About Acorda Therapeutics?
↗
November 09, 2022
Acorda Therapeutics's (NASDAQ:ACOR) short percent of float has risen 230.3% since its last report. The company recently reported that it has 792 thousand shares sold short, which is 3.27% of all...
Via
Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
↗
November 08, 2022
Gainers
Via
Benzinga
Acorda Therapeutics Announces Adjournment of Special Meeting of Stockholders
November 04, 2022
From
Acorda Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 02, 2022
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.
Via
Benzinga
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
November 01, 2022
From
Acorda Therapeutics
Via
Business Wire
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
↗
November 02, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
